| Q42286197 | CXCL6 is an important paracrine factor in the pro-angiogenic human cardiac progenitor-like cell secretome. |
| Q91643965 | Cardiac Progenitor Cells from Stem Cells: Learning from Genetics and Biomaterials |
| Q64090961 | Definition of a cell surface signature for human cardiac progenitor cells after comprehensive comparative transcriptomic and proteomic characterization |
| Q92447152 | Dose-dependent improvement of cardiac function in a swine model of acute myocardial infarction after intracoronary administration of allogeneic heart-derived cells |
| Q90414843 | Electrical Stimulation of pediatric cardiac-derived c-kit+ progenitor cells improves retention and cardiac function in right ventricular heart failure |
| Q92693967 | Extracellular Vesicles Released by Allogeneic Human Cardiac Stem/Progenitor Cells as Part of Their Therapeutic Benefit |
| Q58695517 | Extracorporeal Shock Wave-Supported Adipose-Derived Fresh Stromal Vascular Fraction Preserved Left Ventricular (LV) Function and Inhibited LV Remodeling in Acute Myocardial Infarction in Rat |
| Q97517219 | Human Cardiac Mesenchymal Stromal Cells From Right and Left Ventricles Display Differences in Number, Function, and Transcriptomic Profile |
| Q47144816 | Human Cardiac-Derived Stem/Progenitor Cells Fine-Tune Monocyte-Derived Descendants Activities toward Cardiac Repair |
| Q88884604 | Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges |
| Q52657125 | Recent Progress in Stem Cell Modification for Cardiac Regeneration. |
| Q46299026 | Small molecule signaling, regulation, and potential applications in cellular therapeutics. |
| Q52593734 | Therapeutic Use of Stem Cells for Myocardial Infarction. |